1 -2 (64) 2024 – Teshaev B.K., Kholikova A.O. - WEIGHT CONTROL IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS

WEIGHT CONTROL IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS

Teshaev B.K. Republican Specialized Scientific and Practical Medical Center of Endocrinology named after Academician Y. Kh. Turakulov, Specialized Hospital

Kholikova A.O. Republican Specialized Scientific and Practical Medical Center of Endocrinology named after Academician Y. Kh. Turakulov, Specialized Hospital

Mavlyanova G.U. Republican Specialized Scientific and Practical Medical Center of Endocrinology named after Academician Y. Kh. Turakulov, Specialized Hospital

Resume,

The purpose of the study was to review the literature on weight control in children and adolescents with type 1 diabetes mellitus. We analyzed literature data over the past 20 years. At the same time, trail studies, RCTs, protocols, etc. were studied. According to a review of the literature, the prevalence of obesity in patients with T1DM increased at a faster rate than in the general population. Although intensive insulin therapy, physical inactivity, and the development of double diabetes explain some of the mechanisms of weight gain in patients with T1DM, little has been studied about effective weight control interventions in this population that has long been considered thin. Dietary intervention, increasing physical activity and exercise, adjusting insulin therapy, adding other diabetes medications that have a positive effect on body weight, or adding anti-obesity medications are suggested. Conclusions: 1. The prevalence of obesity in patients with T1DM increased at a faster rate than in the general population. 2. For grade 3 obesity in patients with T1DM, it is recommended to consult a psychologist to rule out eating disorders.

Key words: children and adolescents, type 1 diabetes mellitus, trail studies, weight control, dietary intervention.

First page

2

Last page

11

For citation: Teshaev B.K., Kholikova A.O., Mavlyanova G.U. WEIGHT CONTROL IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS//New Day in Medicine 2(64)2024 2-11 https://newdayworldmedicine.com/en/article/3755/

List of References

  1. Kjær I.Gh, Kolle E., Hansen B.H., Anderssen S.A., Torstveit M.K. Obesity prevalence in Norwegian adults assessed by body mass index, waist circumference and fat mass percentage. // Clinical Obesity. 2015;5(4):211–8. doi:10.1111/cob.12100.
  2. Flegal K.M., Kruszon-Moran D., Carroll M.D., Fryar C.D., Ogden C.L. Trends in obesity among adults in the United States, 2005 to 2014. // JAMA. 2016;315(21):2284-91. doi:10.1001/jama.2016.6458.
  3. Ghosh A., Charlton K.E., Batterham M.J. Socioeconomic disadvantage and its implications for population health planning of obesity and overweight, using cross-sectional data from general practices from a regional catchment in Australia. // BMJ Open. 2016;6(5):e010405. doi:10.1136/bmjopen-2015-010405.
  4. Szadkowska A., Madej A., Ziolkowska K., Szymanska M., Jeziorny K., Mianowska B., et al. Gender and age-dependent effect of type 1 diabetes on obesity and altered body composition in young adults. // Annals of Agricultural and Environmental Medicine: AAEM. 2015;22(1):124–8. doi:10.5604/12321966.1141381.
  5. Conway B., Miller R.G., Costacou T., Fried L., Kelsey S., Evans R.W., et al. Temporal patterns in overweight and obesity in type 1 diabetes. // Diabet Med. 2010;27(4):398–404. doi:10.1111/j.1464-5491.2010.02956.x.
  6. Chillaron J.J., Benaiges D., Mane L., Pedro-Botet J., Flores Le-Roux J.A. Obesity and type 1 diabetes mellitus management. // Minerva Endocrinol. 2015;40(1):53–60.
  7. de Ferranti S.D., de Boer I.H., Fonseca V., Fox C.S., Golden S.H., Lavie C.J., et al. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. // Diabetes Care. 2014;37(10):2843–63. doi:10.2337/dc14-1720.
  8. Secrest A.M., Becker D.J., Kelsey S.F., LaPorte R.E., Orchard T.J. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. // Diabetes. 2010;59(12):3216–22. doi:10.2337/db10-0862.
  9. Russell-Jones D., Khan R. Insulin-associated weight gain in diabetes—causes, effects and coping strategies. // Diabetes Obes Metab. 2007;9(6):799–812. doi:10.1111/j.1463-1326.2006.00686.x.
  10. Valla V. Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps. // Exp Diabetes Res. 2010;2010:178372. doi:10.1155/2010/178372.
  11. Jacob A.N, Salinas K., Adams-Huet B., Raskin P. Potential causes of weight gain in type 1 diabetes mellitus. // Diabetes Obes Metab. 2006;8(4):404–11. doi:10.1111/j.1463-1326.2005.00515.x.
  12. Giuffrida F.M., Bulcao C., Cobas R.A., Negrato C.A., Gomes MB, Dib SA. Double-diabetes in a real-world sample of 2711 individuals: associated with insulin treatment or part of the heterogeneity of type 1 diabetes? // Diabetol Metab Syndr. 2016;8:28. doi:10.1186/s13098-016-0143-7.
  13. DCCTResearchGroup. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. // Am J Cardiol. 1995;75(14):894–903.
  14. Misso M.L., Egberts K.J., Page M., O'Connor D., Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. // The Cochrane database of systematic reviews. 2010;1:CD005103. doi:10.1002/14651858.CD005103.pub2.
  15. Williams K.V., Erbey J.R., Becker D., Orchard T.J. Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study. // Diabetes Care. 1999;22(7):1084–91.
  16. Schechter R., Reutrakul S. Management of severe insulin resistance in patients with type 1 diabetes. // Current diabetes reports. 2015;15(10):1–12. doi:10.1007/s11892-015-0641-2.
  17. Bush M.A. Intensive diabetes therapy and body weight: focus on insulin detemir. // Endocrinol Metab Clin N Am. 2007;36(Suppl 1):33–44.
  18. Timar R., Timar B., Degeratu D., Serafinceanu C., Oancea C. Metabolic syndrome, adiponectin and proinflammatory status in patients with type 1 diabetes mellitus. // J Int Med Res. 2014;42(5):1131–8. doi:10.1177/0300060514541829.
  19. Gomez-Ambrosi J., Catalan V., Ramirez B., Rodriguez A., Colina I., Silva C., et al. Plasma osteopontin levels and expression in adipose tissue are increased in obesity. // J Clin Endocrinol Metab. 2007;92(9):3719–27. doi:10.1210/jc.2007-0349.
  20. Barchetta I., Alessandri C., Bertoccini L., Cimini F.A., Taverniti L., Di Franco M., et al. Increased circulating osteopontin levels in adult patients with type 1 diabetes mellitus and association with dysmetabolic profile. // European Journal of Endocrinology/European Federation of Endocrine Societies. 2016;174(2):187–92. doi:10.1530/EJE-15-0791.

    file

    download